CCL4 and Hepatic fibrosis: As compared to control mice, the progression of liver fibrosis was observed to be decreased in treated mice due to deficiency of HIF-1α in the liver which controlled and inhibited the ethanol and CCL4 promoted liver fibrosis, as revealed by mRNA profile and protein levels of both type-I collagen and α-SMA.